This review explores phage-nanomaterial platforms for enhanced antibacterial activity, suggesting innovative strategies and clinical implications.
This review summarizes the design, antimicrobial mechanisms, and infection-model applications of phage–nanomaterial platforms, highlighting strategies for synergistic antibacterial activity and perspectives for clinical translation.
No takes yet. Share an insight, caveat, or question.
Qi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: